ResMed Stock Price

-0.62 (-0.35%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ResMed Inc RMD NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.62 -0.35% 175.22 173.94 176.03 175.73 175.84 10:50:22
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,007 80,964 $ 175.40 $ 14,200,961 672,251 108.85 - 208.995
Last Trade Time Type Quantity Stock Price Currency
10:50:21 2 $ 175.09 USD

ResMed Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.44B 144.67M 128.78M $ 2.96B $ 620.97M 4.27 49.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.76M $ 1.48 0.84% - -

more financials information »

ResMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week190.00190.90171.69174.681,217,935-14.78-7.78%
1 Month196.84208.995171.69190.03709,253-21.62-10.98%
3 Months161.21208.995149.16179.61701,75814.018.69%
6 Months172.59208.995108.85164.78774,5122.631.52%
1 Year131.15208.995108.85157.58641,59344.0733.6%
3 Years73.02208.99572.49120.57639,651102.20139.96%
5 Years54.76208.99548.9993.76720,289120.46219.98%

ResMed Description

ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.